Research and enlightenment of registration and Declaration system based on e-CTD format in AmericaDING Hui-ying, TIAN Li-juan2121-2128
Discussion on the determination of impurity limits in drug specificationSUN Jia-min, YANG Mei-ling, DU Ying, GENG Ying, HAN Lu, LIU Wan-hui, TAN De-jiang2129-2133
Relevant considerations on pharmaceutical research of generic drugs of compound amino acid injectionWU Xiao-fei, LIU Dan-xing, WANG Hong-liang, BAI Yu2134-2139
Research progress in chemical components and pharmacological effects of the Tibetan medicine AizijinLI Yue-ting, QIN Min-jian, DAI Yi-qun, LI Qi-en, XIE Guo-yong2140-2146
Overview of approaches and applications of deep learning in toxicologic pathology during nonclinical safety evaluation of drugsZHANG Di, YAN Zhen-long, YANG Yan-wei, QU Zhe, HUO Gui-tao, LI Shuang-xing, LIN Zhi, LÜ Jian-jun2147-2154
Research progress of MNK inhibitorsZENG Yang-jie, JIN Peng-yao, CAO Zhi-hao, LI Wen-xin, REN Xiao-dong2155-2163
Research progress on the mechanism of salt-induced kinases(SIKs)in central nervous system diseasesREN Ting-ting, ZOU Man-shu, HAN Yuan-shan, WANG Hua, WANG Yu-hong2164-2172
An analysis of the suspension and termination issues of clinical trialsWANG Rui-kun, LIU Xiao-yu, SHI Kang-le, MENG Qing-gang2173-2177
In vivo toxicokinetics of harmine and derivatives H-2-104 in ratsCHEN Bei, XU Shao-quan, WANG Chang-zhou, ZHAO Bao-yu, CHAI Zhi-gao, Bayan.ahelbk, ZHU Peng-yu, ZHANG Li, ZHAO Jun, MA Qin, GAO Hui-jing2178-2183
Screening of differential quality markers of Poria from different regions by characteristic fingerprints and chemical pattern recognitionLI Peng-hui, LONG Hui-ling, CAI Yuan, GONG Nian-chun, ZHANG Ze-heng, LIAO Xin, PENG Yan-mei2184-2190